Europeans Mull PCSK9i Post-FOURIER Fallout on Clinical Practice Europeans Mull PCSK9i Post-FOURIER Fallout on Clinical Practice

The first PCSK9 outcomes data prompted European Atherosclerosis Society experts to bemoan the cost of PCSK9 inhibitors but also to suggest"there ' s no such thing anymore as too low cholesterol."Heartwire from Medscape
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news